Aaron Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.45M Buy
19,403
+125
+0.6% +$16.5K 0.12% 107
2026
Q1
$2.69M Sell
19,278
-1,089
-5% -$152K 0.15% 85
2025
Q4
$2.5M Buy
20,367
+2,921
+17% +$355K 0.14% 102
2025
Q3
$1.94M Buy
17,446
+4,771
+38% +$542K 0.11% 111
2025
Q2
$1.41M Buy
12,675
+1,522
+14% +$162K 0.14% 99
2025
Q1
$1.25M Buy
11,153
+314
+3% +$32.4K 0.14% 103
2024
Q4
$1M Buy
10,839
+1,474
+16% +$133K 0.12% 120
2024
Q3
$785K Buy
9,365
+2,691
+40% +$205K 0.09% 137
2024
Q2
$458K Buy
6,674
+251
+4% +$16.8K 0.06% 171
2024
Q1
$470K Sell
6,423
-804
-11% -$61.8K 0.07% 159
2023
Q4
$585K Buy
7,227
+44
+0.6% +$3.42K 0.1% 125
2023
Q3
$538K Sell
7,183
-497
-6% -$38.2K 0.07% 140
2023
Q2
$592K Sell
7,680
-219
-3% -$17.5K 0.08% 143
2023
Q1
$655K Buy
7,899
+900
+13% +$74.5K 0.09% 132
2022
Q4
$601K Buy
+6,999
New +$554K 0.09% 135
2022
Q2
Sell
-1,255
Closed -$74.6K 444
2022
Q1
$74.6K Buy
+1,255
New +$80.2K 0.02% 332

Other funds holding GILD

Aaron Wealth Advisors's GILD Position: Q2 2026 in Review

Aaron Wealth Advisors increased its Gilead Sciences (GILD) stake by 0.65% in Q2 2026, buying an estimated $16.5K and bringing the position to 19,403 shares worth $2.45M. The position accounts for 0.12% of the portfolio, ranked #107.

Aaron Wealth Advisors first reported a position in GILD in Q1 2022 and has held it in 16 quarters since. The position peaked at $2.69M in Q1 2026. 2,279 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Aaron Wealth Advisors held 19,403 shares of Gilead Sciences worth $2.45M as of Q2 2026.
  • Aaron Wealth Advisors bought 125 Gilead Sciences shares in Q2 2026, an estimated $16.5K.
  • Gilead Sciences made up 0.12% of Aaron Wealth Advisors's portfolio in Q2 2026, its #107 holding.
  • Aaron Wealth Advisors first reported a position in Gilead Sciences in Q1 2022 and has held it in 16 quarters since.
  • Aaron Wealth Advisors's Gilead Sciences position peaked at $2.69M in Q1 2026.
  • 2,279 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Aaron Wealth Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.